Attorney General Mayes and 20 other states secured a preliminary injunction against the Trump Administration's medical ...

Detailed price information for Netflix Inc (NFLX-Q) from The Globe and Mail including charting and trades.

The NIH nominee also stressed the importance of scientists showing humility and deferring to policymakers when it comes to key issues. The Biden administration had flagged content to social media ...

Bhattacharya emphasized that as director of NIH, he would cultivate a culture of “free speech.” Science, he said, “needs an environment where there’s tolerance for dissent.” Senator ...

Pierre Azoulay is an economist and professor at the MIT Sloan School of Management. Weaknesses in NIH’s 70-plus-year-old institutional approaches are increasingly evident. One sign is that ...

At least 24 termination letters have been sent out, according to one official. Several active research grants related to studies involving LGBTQ+ issues, gender identity and diversity, equity and ...

Widely respected, he served as NIH acting director for two years under President Joe Biden. At 10 a.m. on Jan. 24, Tabak sent a staffwide email. The Trump administration had installed Matthew ...

It came from the Department of Health and Human Services, which oversees the NIH, and arrived with clear instructions: Post this announcement on your website immediately. The memo announced a new ...

“I’ve been told that you have said that we need to invest NIH resources into looking at a possible link between measles vaccine and autism. I’ve not heard that directly; it’s hearsa ...

Collins, who notified the NIH on Friday of his decision, did not specify the reasons for his departure. But his retirement comes as the world's largest public funder of biomedical research is in ...

In December, all of them were reassigned to other offices within the NIH in advance of the second Trump administration, which was expected to dismantle the office. The employees were given little ...

Dr. Lawrence Tabak, the former acting director of the National Institutes of Health (NIH) who admitted to Congress last year that his agency funded risky gain-of-function virus research in China ...